PERINDOPRIL-MEDIS perindopril arginine 5mg film-coated tablet bottle

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

perindopril arginine, Quantity: 5 mg

Disponibbli minn:

Medis Pharma Pty Ltd

INN (Isem Internazzjonali):

perindopril arginine

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: colloidal anhydrous silica; lactose monohydrate; maltodextrin; glycerol dibehenate; magnesium stearate; sodium starch glycollate type A; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

10, 30

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

The treatment of hypertension; The treatment of heart failure. In such patients it is recommended that perindopril be given with a diuretic and/or digoxin under close medical supervision. (The safety and efficacy of perindopril arginine has not been demonstrated for New York Heart Association Category IV patients); and Patients with established coronary artery disease (see Clinical Trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

Sommarju tal-prodott:

Visual Identification: White, oval, biconvex, film-coated tablets engraved with two dots on one side and scored on both sides; Container Type: Bottle; Container Material: HDPE; Container Life Time: 6 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2015-08-07